Healthcare
•3753 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3753)
| Company | Market Cap | Price |
|---|---|---|
|
BDX
Becton, Dickinson and Company
BD offers advanced patient monitoring solutions as part of its healthcare technology portfolio.
|
$59.36B |
$207.11
-0.60%
|
|
AFL
Aflac Incorporated
Aflac sells health-related supplemental insurance (e.g., cancer insurance) as a core product, aligning with Health Insurance.
|
$58.57B |
$109.56
-0.04%
|
|
IDXX
IDEXX Laboratories, Inc.
IDEXX manufactures in-clinic diagnostic instruments and related software (e.g., VetLab analyzers, Catalyst) and provides point-of-care diagnostics.
|
$57.23B |
$715.06
+0.41%
|
|
ZTS
Zoetis Inc.
Zoetis employs monoclonal antibodies for OA pain and dermatology therapies (e.g., Librela, Solensia, Cytopoint), defining a core Monoclonal Antibody Therapeutics product line.
|
$55.24B |
$124.63
-0.52%
|
|
MET
MetLife, Inc.
Health Insurance is offered as part of Group Benefits/employee benefits.
|
$51.05B |
$76.75
-1.48%
|
|
CAH
Cardinal Health, Inc.
Nuclear medicine radiopharmaceuticals distribution and related imaging agents.
|
$50.73B |
$212.35
-0.52%
|
|
TAK
Takeda Pharmaceutical Company Limited
Takeda is a large-cap pharmaceutical company with a diversified, high-revenue drug portfolio and pipeline.
|
$50.48B |
$16.16
-1.04%
|
|
AME
AMETEK, Inc.
Paragon Medical alignment indicates AMETEK provides Medical Device Components as part of its Electromechanical Group.
|
$49.81B |
$215.59
+0.27%
|
|
EW
Edwards Lifesciences Corporation
Core product category including SAPIEN/TAVR, Pascal, Evoque, and SAPIEN M3 used in structural heart interventions.
|
$49.52B |
$84.36
-0.15%
|
|
ARGX
argenx SE
argenx's core offerings are monoclonal antibody therapeutics, including VYVGART.
|
$48.61B |
$800.02
-1.63%
|
|
ALNY
Alnylam Pharmaceuticals, Inc.
Alnylam's core product modality is RNA interference (RNAi) therapeutics, including approved products AMVUTTRA, ONPATTRO, GIVLAARI, and OXLUMO.
|
$47.09B |
$358.97
-0.08%
|
|
HLN
Haleon plc
Panadol and other analgesics position Haleon in OTC Pain Relief & Analgesics.
|
$44.89B |
$9.84
+0.67%
|
|
ROP
Roper Technologies, Inc.
Verathon bronchoscopes and other medical devices place Roper squarely in Medical Devices & Biometrics.
|
$44.78B |
$416.09
+0.44%
|
|
PUK
Prudential plc
Health insurance offerings are a central pillar of Prudential's business strategy and geographic footprint.
|
$44.17B |
$32.08
+0.63%
|
|
IQV
IQVIA Holdings Inc.
IQVIA operates as outsourced drug development and clinical research services akin to a CRO.
|
$40.41B |
$237.75
-1.46%
|
|
PAYX
Paychex, Inc.
Health Insurance; PEO insurance solutions for employees.
|
$40.01B |
$111.18
+0.61%
|
|
A
Agilent Technologies, Inc.
Agilent provides diagnostic instrument platforms used in life sciences and clinical diagnostics.
|
$39.59B |
$139.62
-3.60%
|
|
ALC
Alcon Inc.
Alcon directly designs and manufactures ophthalmology devices including intraocular lenses and surgical platforms.
|
$39.06B |
$78.99
-0.85%
|
|
RMD
ResMed Inc.
CPAP devices and masks are core ResMed medical devices.
|
$37.71B |
$257.57
-1.20%
|
|
BBD
Banco Bradesco S.A.
Health insurance products within Bradesco's Insurance Group.
|
$37.34B |
$3.52
+0.28%
|
|
GEHC
GE HealthCare Technologies Inc.
GE HealthCare's core product portfolio centers on medical imaging devices and imaging systems (CT/MR/PET).
|
$37.32B |
$81.72
-0.95%
|
|
ONC
BeOne Medicines Ltd.
Core oncology-focused biotech; primary business segment is oncology therapeutics.
|
$37.25B |
$337.87
-0.12%
|
|
VTR
Ventas, Inc.
Healthcare Services & Facilities captures ownership/operation of healthcare facilities including senior housing and outpatient spaces.
|
$35.65B |
$78.45
+1.99%
|
|
SLF
Sun Life Financial Inc.
Health insurance offerings (including group health solutions and stop-loss) are key to Sun Life's business.
|
$35.32B |
$62.83
+0.20%
|
|
INSM
Insmed Incorporated
Brensocatib is an oral small molecule therapeutic targeting DPP1, a core part of Insmed's pipeline.
|
$34.12B |
$161.53
+1.42%
|
|
KVUE
Kenvue Inc.
Kenvue directly manufactures and sells OTC analgesics (e.g., Tylenol).
|
$33.01B |
$17.20
-0.35%
|
|
HUM
Humana Inc.
Humana's core revenue and offerings are health insurance products and related services for individuals, employers, and government programs.
|
$32.87B |
$273.27
-3.76%
|
|
NTRA
Natera, Inc.
Natera's Signatera MRD and Signatera Genome tests are liquid biopsy assays using cfDNA to detect minimal residual disease in cancer, a core liquid biopsy product.
|
$31.74B |
$231.26
-3.78%
|
Showing page 3 of 38 (3753 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
